Company page

Insilico Medicine Cayman Topco

Insilico Medicine Cayman Topco, trading under the ticker 3696 on the Hong Kong market, has a market capitalization of approximately 3.58 billion. The company focuses on advancing artificial intelligence-driven drug discovery and development. Its innovative approach aims to enhance the efficiency and effectiveness of pharmaceutical research.